Proceedings from the National Cancer Institute's Second International Workshop on the Biology, Prevention, and Treatment of Relapse after Hematopoietic Stem Cell Transplantation: Part II. Autologous Transplantation—Novel Agents and Immunomodulatory Strategies-Reference-Cited by-同舟云学术

Proceedings from the National Cancer Institute's Second International Workshop on the Biology, Prevention, and Treatment of Relapse after Hematopoietic Stem Cell Transplantation: Part II. Autologous Transplantation—Novel Agents and Immunomodulatory Strategies

Published:2013-12 Issue:12 Volume:19 Page:1661-1669
ISSN:1083-8791
Container-title:Biology of Blood and Marrow Transplantation
language:en
Short-container-title:Biology of Blood and Marrow Transplantation

Author:

Avigan David,Hari Parameswaran,Battiwalla Minoo,Bishop Michael R.,Giralt Sergio A.,Hardy Nancy M.,Kröger Nicolaus,Wayne Alan S.,Hsu Katharine C.

Funder

National Institutes of Health, National Cancer Institute, Center for Cancer Research

National Heart, Lung and Blood Institute

Publisher

Elsevier BV

Subject

Transplantation,Hematology

Reference97 articles.

1. Improved survival in multiple myeloma and the impact of novel therapies;Kumar;Blood,2008

2. Latest advances and current challenges in the treatment of multiple myeloma;Mahindra;Nat Rev Clin Oncol,2012

3. Trends in utilization and outcomes of autologous hematopoietic cell transplantation (AHCT) in the upfront management of patients with multiple myeloma: A CIBMTR analysis;Costa;ASH Annual Meet Abstr,2012

4. International uniform response criteria for multiple myeloma;Durie;Leukemia,2006

5. F18-fluorodeoxyglucose positron emission tomography in the context of other imaging techniques and prognostic factors in multiple myeloma;Bartel;Blood,2009

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Different evasion strategies in multiple myeloma;Frontiers in Immunology;2024-02-23

2. Human CD34+-derived complete plasmacytoid and conventional dendritic cell vaccine effectively induces antigen-specific CD8+ T cell and NK cell responses in vitro and in vivo;Cellular and Molecular Life Sciences;2023-09-20

3. Improved survival rate in T-cell depleted haploidentical hematopoietic cell transplantation over the last 15 years at a single institution;Bone Marrow Transplantation;2019-11-18

4. Natural killer cell immunotherapy against multiple myeloma: Progress and possibilities;Journal of Leukocyte Biology;2018-05

5. Third International workshop on the biology, prevention, and treatment of relapse after stem cell transplantation;Bone Marrow Transplantation;2017-10-09